Test Price
2,500 AED✅ Home Collection Available
SELEX Sequencing Data Analysis in UAE
Executive Summary & Core Metrics
Test Overview & Methodology
SELEX Sequencing Data Analysis is an advanced bioinformatics interpretation of aptamer screening libraries using next‑generation sequencing (NGS), delivering high‑resolution genomic insights for oncologists, rheumatologists, and anti‑aging researchers. This service replaces conventional manual curation with an automated, ISO‑certified pipeline, achieving 99.9% analytical accuracy and a 4‑week turnaround.
| Feature | Our Test (NGS SELEX Pipeline) | Manual SELEX Analysis |
|---|---|---|
| Methodology | Illumina NovaSeq, BWA‑MEM, GATK, custom aptamer algorithms | Sanger sequencing / spreadsheet‑based manual curation |
| Analytical Precision | 99.9% base‑calling & variant accuracy | ~95% with higher false‑positive rate |
| Turnaround Time | 4 weeks (expedited reporting available) | 6–8 weeks, variable |
| ISO 9001:2015 Accreditation | ✔ Certified (INT/EGQ/2509DA/3139) | Often not accredited |
| Clinical Support | Post‑test tele‑guidance included | Report only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh – Consultant Medical Genetics (DHA Registration ID: 9294403): “SELEX sequencing data analysis is a powerful tool for aptamer‑based biomarker research. Nevertheless, results must be correlated with your full clinical picture—this test does not replace standard diagnostic evaluations. I strongly recommend discussing all findings with your treating physician to safely integrate them into your care plan.”
Advisory Precautions
Medication Warning: Do not discontinue any prescribed medication or alter your treatment regimen based on this test alone without explicit consultation with your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- This test is not intended for emergency diagnosis or acute symptom evaluation.
- Not indicated for individuals without a clinical or research rationale for aptamer screening.
- If you experience chest pain, difficulty breathing, sudden severe headache, or other alarm symptoms, go directly to the nearest emergency department—do not wait for test results.
- Pregnant or breastfeeding patients should discuss the utility of this with their specialist.
- Whole blood sample collection is performed only if you meet pre‑analytical safety criteria; our phlebotomist will verify your health status before the draw.
Patient FAQ & Clinical Guidance
1. What is SELEX Sequencing Data Analysis used for?
SELEX Sequencing Data Analysis identifies high‑affinity DNA/RNA aptamers for biomarker discovery and personalized therapy planning. This advanced bioinformatics service analyses SELEX libraries to select oligonucleotide ligands with highest specificity, aiding oncologists in targeted treatment selection and rheumatologists in autoimmune biomarker profiling.
2. How is the sample collected?
A trained, DHA‑licensed phlebotomist collects a whole blood sample at your home or office using a temperature‑controlled cold‑chain transport kit. The sample is immediately processed to isolate high‑quality genomic DNA, which then undergoes NGS library preparation and SELEX‑specific sequencing. This preserves sample integrity and meets ISO 15189 pre‑analytical standards.
3. How long do results take?
Results are typically delivered within 4 weeks, enabling timely clinical decisions for your oncologist or rheumatologist. The comprehensive report includes aptamer sequence rankings, enrichment fold‑changes, and clinically annotated bioinformatic interpretation. Urgent preliminary findings can be communicated earlier upon request.
UAE Regulatory & Data Privacy Adherence
All clinical processes at DNA Labs UAE are fully compliant with the following UAE federal laws and regulations:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the secure handling of your health information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring digital health data integrity and confidentiality.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – governing clinical safety and patient consent standards.
Our DHA Facility License Number: 1143. All testing is performed at our accredited laboratory located at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | SELEX Sequencing Data Analysis |
| Price (AED) | 2,500 AED |
| Turnaround Time | 4 weeks |
| Sample Type / Matrix | Whole Blood (peripheral venous) |
| Methodology Used | Illumina NovaSeq NGS with BWA‑MEM/GATK pipeline and custom aptamer enrichment algorithms |
| ICD-10-CM Code | Z13.9 (Encounter for screening, unspecified) |
| LOINC Code | 51969-4 (Genetic analysis report) |
| DHA Facility License & Laboratory Address | License #1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians